PTSystematic ReviewJournal of rehabilitation medicine2024

Exercise-based telerehabilitation for patients with multiple sclerosis using physical activity: a systematic review.

Michaela Sladeckova, Jan Kocica, Eva Vlckova and 4 others

PMID 39539070

WHAT IT FOUND

Six of ten trials found telerehabilitation beat usual care for walking, strength or motor function in multiple sclerosis, but the trials tested different exercises, outcomes and lengths, so no particular programme can be recommended.

Adherence fell as programmes got longer.

Key findings

01Five of the ten trials showed significant improvement in the telerehabilitation group and six reported a significant difference between the telerehabilitation and control groups. Two trials also improved in the control group, and the trials were too varied in intervention and outcome to combine.

02Adherence followed how long the programme ran: the two shortest trials, of 6 to 8 weeks, reported over 95%, five trials of 12 to 14 weeks averaged 67%, and the 48-week trial reported 50%. In one trial delivering the same programme at home and at the centre, home adherence was 45% against 83% at the centre.

03Only five of the ten trials described adverse events. Three reported none, and in the two trials where events occurred they were reported as unrelated to the exercise intervention.

STILL TO COME

How it was doneWhat they foundWhat it means for PTs

Read the rest of this summary

You get three full summaries a month, free, and we do not ask for a card. Search, the TL;DRs and your library stay unlimited either way.

Already have one?

What it does not show

Only two databases were searched, so relevant studies may have been missed. Only published, English-language studies were included, and the authors acknowledge that negative findings may go unreported. No pooled analysis was possible. The trials used different exercises, different outcome measures and different definitions of telerehabilitation, so the results cannot be combined or applied across settings. The samples were small, from 10 to 139 people per telerehabilitation group, and varied widely in age, disability level and type of MS. Participants were likely to be younger, more motivated and already inclined towards technology-based rehabilitation, so the results may not apply to people who are not. Only five of ten trials reported adverse events, so the safety picture rests on thin reporting. Adherence was measured in different ways across trials, so the comparisons between them are loose. The authors note that the evidence for any disease-modifying effect of exercise in MS is speculative and based on minimal evidence.

Declared interests

The authors declare no conflicts of interest. The text supplied does not say who funded the review.

The easy way to misread this

Do not read this as proof that telerehabilitation works as well as usual care. The ten trials could not be combined because they used different exercises and outcome measures, several were small, and in two trials the control group improved as well, so the review reports what individual trials found rather than one pooled answer.

Summarised by AI from the full paper, without a clinician reviewing it. Check it against the source before it changes what you do. Read it on PubMed →